Posaconazole Tablet, Delayed Release
Product Images NDC 17856-2133

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Posaconazole (NDC 17856-2133). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atlantic Biologicals Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (17856 2133 01)

POSACONAZOLE 100 mg delayed-release oral tablets label showing product name, strength, dosage form, quantity of 100 tablets, and storage instructions. The label includes barcode, serial number, expiration date, lot number, and contact information for reorder. Distributed by Atlantic Biologicals Corp and packaged by Unit Dose Solutions.*

FDA Label Image

1 (6369970a 9b52 4fac 990f B470aa3057aa 1)

Chemical structure of posaconazole, shown as a complex molecular diagram including fluorinated aromatic rings, azole groups, and various functional groups representing the active ingredient posaconazole.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.